Viimane versioon :
08/05/2024
InfoStab
Infostab
Ingredientide nimekiri
Ingredientide nimekiri
Nimekiri
Nimekiri
Sobivus otsing
Sobivus otsing
Y-liini sobivuse tabel
Y-liini sobivuse tabel
Viited
Viited
Uurimisrühmad
Uurimisrühmad
Valistab
Valistab
Plakat
Plakat
Sidemed
Sidemed
Sponsorid
Sponsorid
Autor
Autor
Kasutusjuhend
Kasutusjuhend
Ajakiri
Ajakiri
Antibiootikum   Pentamidine isetionate  
Süsteravim
Stabiilsus lahustes Stabiilsust mõjutavad tegurid Stabiilsust mõjutavad faktorid Sobimatus Manustamis viis Viited Pdf
   Keemiline struktuur  

Kaubanduslikud nimed erinevates maades   Kaubanduslikud nimed erinevates maades     

Preparaatide nimed on näitlikud ja abianete sisaldus võib erineda sõltuvalt riigist ja laborist
DBL Pentamidine isetionate Malaisia
Manicare Argentiina
Nebupent Ameerika ühendriigid
Pentacarinat Austria, Belgia, Hispaania, Holland, Itaalia, Kolumbia, Kreeka, Luksemburg, Prantsusmaa, Rootsi, Saksamaa, Soome, Suurbritannia, Sveits, Taani, Uus-Meremaa
Pentam Ameerika ühendriigid
Pentamidina Argentiina, Hispaania
Pentamidine isethionate Ameerika ühendriigid, Austraalia, Kanada, Malaisia
Pentamina Portugal
Viited   Süsteravim   Viited : Pentamidine isetionate  
Tüüp Avaldamine
36 Ajaleht Alex S, Gupta SL, Minor JR, Turcovski-Corrales S, Gallelli JF, Taub D, Piscitelli SC.
Compatibility and activity of aldesleukin (recombinant interleukin-2) in presence of selected drugs during simulated Y-site administration: Evaluation of three methods.
Am J Health-Syst Pharm 1995 ; 52: 2423-2426.
73 Ajaleht Lor E, Takagi J.
Visual compatibility of foscarnet with other injectable drugs.
Am J Hosp Pharm 1990 ; 47: 157-159.
198 Ajaleht Gayed AA, Kheshary PR, Hinkle RL.
Visual compatibility of diltiazem injection with various diluents and medications during simulated Y-site injection.
Am J Health-Syst Pharm 1995 ; 52: 516-520.
275 Ajaleht Lewis JD, El-Gendy A.
Cephalosporin-pentamidine isethionate incompatibilities.
Am J Health-Syst Pharm 1996 ; 53: 1461-1462.
337 Ajaleht Bashaw ED, Amantea MA, Minor JR, Galleli JF.
Visual compatibility of zidovudine with other drugs during simulated Y-site administration.
Am J Hosp Pharm 1988 ; 45: 2532-2533.
424 Ajaleht De NC, Alam AS, Kapoor JN.
Stability of pentamidine isethionate in 5% dextrose and 0.9% sodium chloride injections.
Am J Hosp Pharm 1986 ; 43: 1486-1488.
496 Ajaleht Lor E, Sheybani T, Takagi J.
Visual compatibility of fluconazole with commonly used injectable drugs during simulated Y-site administration.
Am J Hosp Pharm 1991 ; 48: 744-746.
604 Labor Stabilité des médicaments dans l'Intermate® SV50, 100, 200
Baxter 1998
1135 Ajaleht Baltz JK, Kennedy P, Minor JR, Gallelli J.
Visual compatibility of foscarnet with other injectable drugs during simulated Y-site administration.
Am J Hosp Pharm 1990 ; 47: 2075-2077.
1235 Ajaleht Leigh PH, Buddle GC.
Pentamidine infusion stability.
Br J Pharm Pract 1988 ; 10: 22-23.
1625 Ajaleht Trissel LA, Saenz C, Williams YW, Ingram D.
Incompatibilities of lansoprazole injection with other drugs during simulated Y-site coadministration.
Int J Pharm Compound 2001 ; 5: 314-321.
1925 Ajaleht Trissel LA , Williams KY, Gilbert DL.
Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions.
J Am Pharm Assoc 2000 ; 40: 515-519.
3543 Labor Ceftazidime – Summary of Product Characteristics
Wockhardt 2013
3559 Labor Pentamidine diiséthionate (Pentacarinat®) - Résumé des caractéristiques du produit
Sanofi Aventis France 2013
3560 Labor Linezolid (Zyvox®) - Summary of Product Characteristics
Pharmacia 2013
3662 Labor Foscavir (Foscarnet®) - Summary of Product Characteristics
Clinigen 2014
  Mentions Légales